62910 Rational and efficacy of janus kinase inhibitor switching for alopecia areata
Mengxi Yu, Maria Colavincenzo(Northwestern University), Janaya Nelson, Edward Li(Sanden (Japan)), Victor L. Quan(Northwestern University)
Cited by 0
Related Papers
Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development
|Developmental Cell|2008|231
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
|The Journal of Cell Biology|2017|175
Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database
|BMC Public Health|2018|85
Projecting future drug expenditures—2012
|American Journal of Health-System Pharmacy|2012|81
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
|Journal of the American Academy of Dermatology|2022|80